19 Jun, 12:09 - Indian

Nifty Next 50 66288.9 (-0.75)

Nifty 50 24815.9 (0.02)

SENSEX 81429.1 (-0.02)

Nifty Bank 55661.45 (-0.30)

Nifty Midcap 100 57551.95 (-0.96)

Nifty Smallcap 100 18158.6 (-1.20)

Nifty IT 38662.2 (-0.94)

Nifty Pharma 21492.85 (-0.44)

19 Jun, 12:09 - Global

NIKKEI 225 38488.34 (-1.02)

HANG SENG 23218.43 (-2.08)

S&P 5973 (-0.34)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(22 Nov 2024, 13:23)

Marksans Pharma gains after receiving final nod for Loratadine Tablets from USFDA

Marksans Pharma rose 1.94% to Rs 315 after the company received final approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) , Loratadine Tablets.


The said drugs are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies.

This product is generic version of Clartin tablet in the same strength of Bayer Healthcare.

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.

The company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 over Q2 FY24.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +